Table A2.
Drug | Examination | Cure | Unclassified Items | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
β a | SE b | p Value | β a | SE b | p Value | β a | SE b | p Value | β a | SE b | p Value | |
Baseline trend c | 1.43 | 0.25 | 0.000 | 0.61 | 0.14 | 0.000 | 0.22 | 0.05 | 0.000 | 0.16 | 0.03 | 0.000 |
Level change 1d | −13.39 | 3.34 | 0.000 | −3.95 | 1.88 | 0.036 | −1.92 | 0.50 | 0.000 | −0.74 | 0.49 | 0.128 |
Trend change 1e | −0.78 | 0.28 | 0.005 | −0.17 | 0.14 | 0.248 | −0.06 | 0.04 | 0.125 | −0.09 | 0.04 | 0.021 |
Level change 2f | −9.22 | 3.17 | 0.004 | −3.25 | 1.58 | 0.040 | −1.83 | 0.52 | 0.000 | −0.02 | 0.41 | 0.965 |
Trend change 2g | 0.30 | 0.29 | 0.296 | 0.03 | 0.13 | 0.836 | −0.06 | 0.04 | 0.118 | −0.09 | 0.04 | 0.015 |
Gender (Male, %) | −147.47 | 79.00 | 0.062 | −77.60 | 44.29 | 0.080 | −19.38 | 14.48 | 0.181 | −6.76 | 10.07 | 0.502 |
Age (>65, %) | 134.56 | 36.30 | 0.000 | 53.79 | 19.95 | 0.007 | 20.01 | 5.31 | 0.000 | −3.41 | 7.11 | 0.631 |
second quarter | −5.29 | 2.45 | 0..031 | −1.28 | 1.22 | 0.29 | −0.19 | 0.35 | 0.589 | −0.01 | 0.36 | 0.987 |
third quarter | −6.49 | 2.50 | 0.009 | −1.63 | 1.48 | 0.269 | −0.45 | 0.38 | 0.267 | −0.73 | 0.48 | 0.125 |
fourth quarter | −6.21 | 3.08 | 0.043 | −2.48 | 1.77 | 0.161 | −0.50 | 0.49 | 0.308 | −0.79 | 0.53 | 0.137 |
Cons | 41.76 | 55.88 | 0.455 | 26.39 | 30.02 | 0.379 | 5.29 | 10.23 | 0.605 | 11.97 | 8.06 | 0.138 |
AR1 | −0.06 | 0.12 | 0.617 | −0.08 | 0.19 | 0.668 | −0.23 | 0.19 | 0.233 | −0.41 | 0.19 | 0.027 |
AR2 | −0.68 | 0.13 | 0.000 | −0.64 | 0.13 | 0.000 | −0.67 | 0.12 | 0.000 | −0.56 | 0.17 | 0.001 |
Ljung−Box Q | 11.11 | / | 0.973 | 14.45 | / | 0.885 | 15.50 | / | 0.840 | 29.03 | / | 0.144 |
a Coefficient of each variety; b Standard error of each variety; c Baseline time trend of dependent variable; d, e, f, g Instant change and time trend change of GBPS pilot and implemented.